In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
Seshasayee D, Lee WP, Zhou M, Shu J, Suto E, Zhang J, Diehl L, Austin CD, Meng YG, Tan M, Bullens SL, Seeber S, Fuentes ME, Labrijn AF, Graus YM, Miller LA, Schelegle ES, Hyde DM, Wu LC, Hymowitz SG, Martin F.
Seshasayee D, et al. Among authors: lee wp.
J Clin Invest. 2007 Dec;117(12):3868-78. doi: 10.1172/JCI33559.
J Clin Invest. 2007.
PMID: 18060034
Free PMC article.